Fibroblast growth factors (FGFs) are a family of heparin binding proteins involved in many biological processes. These growth factors act through tyrosine kinase receptors (FGFRs); we have previously used immunohistochemistry to study FGFRs-1-4 in foetal, immature and adult rat testes, and found a discrete cell-and stage-specific localisation. Alternative mRNA splicing of FGFRs-1-3 leads to functional variants (IIIb and IIIc) with distinct ligand binding affinities, therefore we have identified the specific expression of functional FGFR variants and the expression and localisation of FGF ligands in testes from foetal, immature and adult rats. Using reverse transcriptasepolymerase chain reaction (RT-PCR), we found that mRNAs for FGFR-1 IIIb and IIIc, FGFR-2 IIIc, FGFR-3 IIIc and FGFR-4 were expressed in foetal, immature and adult testes. Ligands FGFs-1-5, and -8, which can signal through these receptors, were also expressed in testes at each age. Localisation of the ligands FGFs-1, -3 and -4 to rat testes by immunohistochemistry showed a discrete cell-and stage-specific localisation that altered during testis development. This study has shown that the ligands FGFs-1, -3 and -4 are expressed in the testis and have the capacity to signal through appropriate receptors that are also co-localised or expressed in adjacent cell types in the testis. Collectively, the expression profiles of the seven FGFR variants and FGFs-1-5 and -8 suggest a functional importance in testicular development and spermatogenesis. It is concluded that, future studies on the role of other FGF ligands, in particular FGFs-1-4, are warranted.
Introduction
Fibroblast growth factors (FGFs) are a family of heparin binding proteins involved in many biological processes during embryonic development and homeostasis in the adult (Goldfarb 1996) . The FGF family has at least 19 members (Nishimura et al. 1999) , but most studies in the testis have concentrated on the expression, localisation or action of only FGFs-1, -2, and -8. Four genes encode the FGF receptors (FGFRs), which are characterised by three extracellular immunoglobulin-like loops, a transmembrane domain and a split tyrosine kinase domain (McKeehan et al. 1998) . For FGFRs-1-3, alternative mRNA splicing of loop III leads to distinct functional variants (IIIb and IIIc) with different ligand affinities, whereas FGFR-4 is most similar to a IIIc-like domain (Vainikka et al. 1992) . The ligand-receptor interactions in vitro have been determined for FGFs-1-10 ; these studies suggest that the IIIc variants are utilised by more ligands than the IIIb variants. Activation of the FGFs by their receptors requires a third component, the heparan sulphate proteoglycans (HSPGs). Various models have been proposed by which heparan sulphate, FGFs and FGFRs interact to promote signalling (Guimond et al. 1993 , Kan et al. 1993 , Pantoliano et al. 1994 , McKeehan et al. 1998 , Pye & Gallagher 1999 . Findings of the recent study by Pye & Gallagher (1999) suggest that a monomeric complex of FGF and heparan sulphate docks with an FGFR monomer to facilitate dimerisation through two FGFR binding interfaces on the growth factor.
Previous studies of FGFR-1 expression in testis have not discriminated between the two functional variants (Han et al. 1993 , Le Magueresse-Battistoni et al. 1994 . The expression and localisation of FGFs-2 (Han et al. 1993 , Ueno et al. 1987 , Mayerhofer et al. 1991 , Mullaney & Skinner 1992 , Koike & Noumura 1994 and -8 (Schmitt et al. 1996 , Valve et al. 1997 , Wu et al. 1997 have been reported in testes, and the functions of FGFs-1 and -2 have been examined using in vitro cell systems. However, data are limited to FGF-2 regulation of gonocyte proliferation (Van Dissel-Emiliani et al. 1996) , and FGFs-1 and -2 regulation of Leydig cell function in vitro (Fauser et al. 1988 , Murono et al. 1993 , Laslett et al. 1997 . The physiological relevance is difficult to determine in view of the discrete, specific localisation of the receptors that we have described (Cancilla & Risbridger 1998) . We observed a change in the distinct profile of FGFR proteins detected with development and maturation of the testis, suggesting that ligand interactions within and between these compartments are important and more complex than previously considered.
In the testis, immunolocalisation studies were performed using antibodies that could not discriminate between the IIIb and IIIc variants of FGFRs-1-3 (Han et al. 1993 , Cancilla & Risbridger 1998 . The aim of the present study was to use reverse transcriptase-polymerase chain reaction (RT-PCR) to confirm and extend the immunolocalisation data by determining which receptor variants (FGFRs-1-3 IIIb and IIIc, and -4) are expressed in foetal, immature and adult rat testes. Each specific FGFR variant can interact with a particular array of FGF ligands, so we used RT-PCR again to determine which ligands (FGFs-1-10) are expressed in testis. FGFs-4 and -8, in addition to FGFs-1 and -2, are highly active ligands of the FGFR variants we detected. We used immunohistochemistry to localise FGFs-1, -3, -4 and -8 in developing and adult testes, and report their localisation with reference to the receptors through which these ligands are able to signal. The particular array of FGFR variants and FGFs expressed in the testis, in association with their discrete cell-and stage-specific localisation, suggests a highly regulated interaction between ligands and receptors during testicular development and spermatogenesis.
Materials and Methods

Animals
Intact male Sprague-Dawley outbred rats at 20 days (n=3) and 90-100 days (n=3) post-partum were killed in a CO 2 -charged chamber, and the testes removed, decapsulated and snap frozen. Samples of kidney and skeletal muscle were also taken from adult rats for positive controls. Adult males (90-100 days post partum; n=6) were similarly killed, the testes removed and decapsulated, and adult Leydig cells isolated, as previously described (Risbridger & Davies 1994) . The purity of the adult Leydig cells was approximately 99% (Laslett et al. 1997) . A comparison of FGF and FGFR expression in foetal, immature and adult Leydig cells was not possible in this study, as foetal and immature Leydig cell preparations are contaminated with other cell types. Pregnant females at 19·5 days gestation (n=4) were anaesthetised with diethyl ether, and foetuses were removed and quickly decapitated before the mother was killed. Testes were dissected from male foetuses (n=25), decapsulated and snap frozen. For immunohistochemistry, tissues were obtained as previously described (Cancilla & Risbridger 1998) . All animals were obtained from Central Animal Services, Monash University. Procedures and animal care were administered according to requirements, and with the approval of the Standing Committee of Ethics in Animal Experimentation, Monash University.
RNA preparation
Total RNA was isolated from tissue samples using Trizol Reagent (Gibco BRL, Gaithersburg, MD, USA) according to manufacturer's instructions. Testicular and Leydig cell mRNA was then isolated using the PolyATract mRNA Isolation System (Promega, Madison, WI, USA), also according to manufacturer's instructions. Three preparations of mRNA were isolated from testes at each age, and two preparations of adult Leydig cells (pooled from three rats each). The RNA concentration of each sample was measured using a GeneQuant-II RNA/DNA Calculator (Pharmacia Biotech, Uppsala, Sweden), and all mRNA samples were adjusted to a concentration of approximately 4·5 µg/ml.
Oligonucleotide primers
Oligonucleotide primers used for amplification of FGFs-1-10 were designed against rat or mouse cDNA sequences and purchased from Bresatec (Adelaide, SA, Australia). Primers used are listed in Table 1 . For amplification of a 355 bp product for FGF-2, p1 and p2 were used as forward and reverse primers, respectively (El-Husseini et al. 1992) , with Ra1 (Ford et al. 1997) as the internal oligonucleotide used for Southern blot analysis. Oligonucleotide primers used for amplification of 450 bp products for FGFRs-1-4 transmembrane (tm) domains and 350 bp products for FGFRs-1-3 IIIb and IIIc variants were identical to those used previously for amplification from adult rat kidney (Ford et al. 1997) .
RT-PCR
Reverse transcription and PCR were performed sequentially in the same reaction tube using a GeneAmp RNA PCR kit (Perkin Elmer, Foster City, CA, USA) according to manufacturer's instructions. RT-PCR was performed in a Perkin Elmer Cetus DNA Thermal Cycler (Perkin Elmer Instrument Division, Norwalk, CT, USA). RT of approximately 4 ng testicular mRNA (or approximately 1 µg total RNA from skeletal muscle and kidney) and 50 ng appropriate reverse primer was performed at 42 C for 30 min to generate cDNA. Hot-start PCR was then performed using an Ampliwax PCR Gem (Perkin Elmer) to form a solid barrier before addition of 50 ng appropriate forward primer and PCR components. A final concentration of 2 mM MgCl 2 was used, except for amplification of FGFR-4(tm), for which 3 mM MgCl 2 was used. PCR was performed for 35 cycles, with 1 min at 95 C for denaturation, 1 min at either 55 C or 60 C for annealing and 1 min at 72 C for extension. Controls for RT-PCR omitted the reverse transcriptase (non-RT control), or RNA (water control), which were replaced with water. RT-PCR was performed twice on each mRNA sample for each transcript examined.
Southern blot analysis
RT-PCR products were electrophoresed through a 1·4% agarose-1 TBE gel and were compared with a 100 bp DNA ladder (Gibco BRL) to determine the size of the PCR products (data not shown). The RT-PCR products were then alkaline-capillary-blotted onto Hybond N+ membrane (Amersham Life Science, Little Chalfont, Bucks, UK) as described by Sambrook et al. (1989) . RT-PCR products were detected by hybridisation at 42 C for 18 h with their respective internal oligonucleotides, which were radioactively labelled by 5 end labelling using [ -32 P]-ATP (NEN, Boston, MA, USA) and T4 polynucleotide kinase (Boehringer Mannheim, Castle Hill, NSW, Australia). After stringent washes in 0·5 SSC-0·1% SDS at 42 C, membranes were exposed to either X-OMAT AR or BIOMAX AR scientific imaging film (Eastman Kodak Co., Rochester, NY, USA) with intensifying screens at either room temperature or 70 C. The identities of most of the FGF and all the FGFR RT-PCR products detected by Southern blot analysis were confirmed by direct sequencing of PCR products on an automated ABI 310 Prism DNA sequencer (Applied Biosystems, Melbourne, Victoria, Australia).
Immunohistochemistry
Immunohistochemistry was performed as previously described (Cancilla & Risbridger 1998) , except for the trypsin pretreatment of sections, which was replaced with a microwave antigen-retrieval step in 10 mM glycine (pH 6·0) for FGF-1, 10 mM citrate (pH 6·0) for FGFs-3 and -8, and 10 mM Tris (pH 4·5) for FGF-4 (1000 W microwave oven, 3 min high power, 5 min low power).
Antibodies used were affinity-purified goat anti-FGF-1 (raised against a peptide mapping at the carboxy (C) terminus of human FGF-1), affinity-purified goat anti-FGF-3 (raised against a peptide mapping at the C terminus of mouse FGF-3), and affinity-purified goat anti-FGF-4 (raised against a peptide mapping at the C terminus of human FGF-4) from Santa Cruz Biotechnology (Santa Cruz, CA, USA); the peptide sequences used to generate these antibodies are identical in rat. Affinity-isolated goat anti-recombinant mouse FGF-8 immunoglobulin G (IgG) was a gift from R & D Systems (Minneapolis, MN, USA). Biotinylated, affinity-isolated rabbit anti-goat IgG (Dako, Botany, NSW, Australia) was used as a secondary antibody. Anti-FGF-3 and -4 antibodies were used at 1 µg/ml, and anti-FGF-1, -8, and secondary antibodies were used at 2 µg/ml. The FGF-8 antibodies were also tested on sections of E10 mouse embryos as a positive control (data not shown).
Replacement of the primary antibody with affinityisolated goat IgG (Zymed Laboratories, South San Francisco, CA, USA), or preabsorption of each antibody with 10 excess of corresponding immunising peptide (20 µg/ml for FGF-1, and 10 µg/ml for FGFs-3 and -4; Santa Cruz Biotechnology), were used as controls. Serial sections were incubated with antibodies and controls to determine whether positive immunostaining of a particular structure was specific. (Fig. 1) RT-PCR indicated that mRNAs for FGFRs-1 (446 bp RT-PCR product), -2 (452 bp RT-PCR product), -3 (431 bp RT-PCR product) and -4 (434 bp RT-PCR product) were present in foetal, immature and adult rat testes. Expression of FGFR-4 (which has no alternate splicing of loop III) was also examined in preparations of adult Leydig cells, where RT-PCR products of the expected size were detected. No RT-PCR products were detected in the water or non-RT controls of any sample (Table 2) .
Results
RT-PCR for FGFRs-1-4 transmembrane domain
RT-PCR for FGFRs-1-3 IIIb and IIIc variants (Fig. 2)
RT-PCR products of the expected size for FGFRs-1 IIIb (350 bp), -1 IIIc (348 bp), -2 IIIc (318 bp) and -3 IIIc (331 bp) variants were present in foetal, immature and adult testes. FGFRs-2 IIIb (360 bp RT-PCR product) and -3 IIIb (351 bp RT-PCR product) were expressed in the positive control kidney sample, but were not expressed by testes at any age examined. Isolated adult Leydig cells were found to express only FGFRs-1 IIIb, -1 IIIc and -2 IIIc, but not the other FGFR variants. No RT-PCR products were detected in the water or non-RT controls of any sample (Table 2) .
RT-PCR for FGFs-1-10 (Fig. 3)
RT-PCR indicated that mRNAs for FGFs-1 (307 bp RT-PCR product), -2 (355 bp RT-PCR product), -3 (372 bp RT-PCR product), -4 (261 bp RT-PCR product), -5 (414 bp RT-PCR product), -7 (384 bp RT-PCR product) and -8 (384 bp RT-PCR product) were expressed in testes from foetal, immature and adult rats.
FGF-10 (548 bp RT-PCR product) was detected in foetal testes but not at any other age. FGFs-6 (492 bp RT-PCR product) and -9 (411 bp RT-PCR product) were expressed in the positive control skeletal muscle and kidney respectively, but no expression was detected in testes at any age examined. A limited number of FGF mRNAs were detected in isolated adult Leydig cells, where only FGFs-1, -2 and -7 RT-PCR products were amplified. No RT-PCR products were detected in the water or non-RT controls of any sample ( Table 2) . (Fig. 4) The specificity of FGFs for each FGFR variant has been determined using a mitogenic cell assay . The data pertaining to those FGFs and FGFRs expressed in testis have been selected and are presented in Fig. 4 in three-dimensional form, to enable easy crossreferencing of the relative activity of different FGF and FGFR variants. These results suggest that, in addition to FGFs-1 and -2, other FGFs expressed in the testes may also be important ligands of the testis-expressed FGFR variants. In particular, FGF-3 only binds to FGFR-1 IIIb, FGF-8 binds FGFRs-3 IIIc and -4, and FGF-4 is a major ligand of the IIIc variants of each receptor. Therefore we localised these proteins by immunohistochemistry in developing, immature and adult testes.
Specificity of FGFs for FGFRs
Immunolocalisation of In the adult rat testis, FGF-1 immunoreactivity was predominantly localised to the interstitium, in particular to the adult Leydig cells (Fig. 5A) . Immunostaining was also observed in Sertoli cells, and faint immunostaining was observed in round spermatids of stage I-VI tubules (Fig. 5A) . Acrosome staining was an artefact observed with this antibody, as staining was not removed by preabsorption. In the immature testis, immunostaining for FGF-1 was observed in the immature adult-like Leydig cells and peritubular cells of the interstitium (Fig. 5B) ; no specific immunoreactivity was observed in the epithelium. In the foetal testis, immunoreactivity for FGF-1 was present in gonocytes and foetal Leydig cells (Fig. 5C) . In contrast to FGF-1, FGF-3 was specifically localised to elongating spermatids in stage I-VI tubules in adult testes (Fig. 5D) ; no FGF-3 immunoreactivity was observed in the interstitium. No specific staining was observed for FGF-3 in the immature rat testis (Fig. 5E ) or in the foetal testis (Fig. 5F) .
A distinct pattern of FGF-4 immunoreactivity was observed in rat testes. In the adult testis, FGF-4 was localised to pachytene spermatocytes of stage V-XI tubules, and to step 7-12 spermatids of stage VII-XII tubules (Fig. 5G) ; no immunostaining was observed in the interstitium. Again, the acrosome staining observed was an artefact. In the immature testis, pachytene spermatocytes and immature adult-like Leydig cells were immunoreactive for FGF-4 (Fig. 5H ). In the foetal rat testis, FGF-4 immunostaining was evident in foetal Leydig cells and also in gonocytes (Fig. 5I) .
Although FGF-8 mRNA was detected in rat testes by RT-PCR, no immunoreactivity for FGF-8 was detected in testes at any age examined (data not shown).
No immunostaining was observed when goat IgG was used instead of the primary antibodies (data not shown). The cytoplasmic immunoreactivity observed for FGFs-1, -3 and -4 was neutralised when these antibodies were preabsorbed with their corresponding peptides (Fig. 5 inset  photomicrographs) .
Discussion
This comprehensive study has identified the differential expression of functional FGFR variants and FGF ligands in foetal, immature and adult rat testes, thus extending our previous immunohistochemical studies on FGFRs (Cancilla & Risbridger 1998) . The discrete expression and localisation of FGFs-1, -3 and -4, together with their appropriate receptors, suggest specific roles for these ligands in testicular development and function.
Our previous data localised all four FGFRs to testes (Cancilla & Risbridger 1998 ), and we have now shown that only five of the seven functional variants are expressed. FGFR-1 mRNA expression (Han et al. 1993 , Le Magueresse-Battistoni et al. 1994 ) and localisation of FGFR-1 protein to epithelium and interstitium (Han et al. 1993 , Cancilla & Risbridger 1998 ) have been described in testes. The antibodies used for FGFR-1 immunolocalisation could not discriminate between the IIIb and IIIc variants (Han et al. 1993 , Cancilla & Risbridger 1998 ). Our present data showed that both variants of FGFR-1 were present in whole testis and isolated adult Leydig cells. Many FGF ligands can act through FGFRs-1 IIIb and IIIc, and we have shown that mRNAs for FGFs-1-5 were expressed in rat testes. FGFR-2 protein was immunolocalised to spermatocytes and spermatids of immature and adult testes and to Leydig cells (Cancilla & Risbridger 1998) . We suggest this must be due to FGFR-2 IIIc, as FGFR-2 IIIb was not expressed. Ornitz and co-workers (1996) used an FGFR variant BaF3 cell line mitogenic assay and reported that many FGF ligands can signal through FGFR-2 IIIc, with varying affinities. The mRNAs for FGFs-1, -2 and -4 (highly mitogenic) and FGFs-5 and -8 (less mitogenic) were all expressed in rat testes, but only FGFs-1 and -2 were expressed in Leydig cells.
RT-PCR revealed that FGFR-3 IIIb mRNA was not expressed in rat testes, therefore our previous localisation of FGFR-3 to foetal gonocytes, immature spermatocytes and specific adult spermatocytes (Cancilla & Risbridger 1998) must be attributed to FGFR-3 IIIc. The absence of FGFR-3 expression in isolated Leydig cells was confirmed by RT-PCR. FGFRs-3 IIIc and -2 IIIc act as receptors for a similar range of ligands and, as they have been differentially localised, specific localisation of their ligands would determine which paracrine or autocrine interactions were important during spermatogenesis. Our previous study showed FGFR-4 was localised to Sertoli cells, germ cells and Leydig cells (Cancilla & Risbridger 1998) , and RT-PCR confirmed FGFR-4 expression in testis and isolated adult Leydig cells. FGFs-1, -2, -4 and -8 activate FGFR-4 , and these were expressed in testes, whereas only FGFs-1 and -2 were expressed in Leydig cells.
The expression of five functional FGFR variants suggests that several possible receptor-ligand interactions may occur during testicular development and spermatogenesis. In foetal testes, FGF-2 is a survival factor for Sertoli cells, and a mitogenic factor for gonocytes (Van Dissel-Emiliani et al. 1996) , whereas FGFs-1 and -2 modulate Leydig cell steroidogenesis (Fauser et al. 1988 , Murono et al. 1993 , Laslett et al. 1997 . The results of the present study suggest that other FGFs may be important for these FGFR variants.
The three-dimensional graph of FGF-FGFR interactions (Fig. 4) indicates that FGFR-1 IIIb is the only receptor through which FGF-3 can act in the testis . Although FGF-3 mRNA was detected by RT-PCR throughout development, FGF-3 protein was found only in adult testis, where greater detectable amounts suggest functional significance. FGF-3 localisation overlaps with that of FGFR-1 protein (Cancilla & Risbridger 1998) , suggesting a specific action on Figure 3 RT-PCR and Southern blot analysis of FGFs-1-10 in the rat testis. Lanes are labelled for foetal rat testis (FT), immature rat testis (IT), adult rat testis (AT), adult Leydig cells (LC), and positive-control adult skeletal muscle (SM) and kidney (K). , Non-RT controls for each sample; H 2 O, RNA-free controls for each FGFR assayed. RT-PCR products for FGFs-1 (307 bp), -2 (355 bp) and -7 (384 bp) were detected in foetal, immature and adult testes, and in adult Leydig cells. RT-PCR products for FGFs-3 (372 bp), -4 (261 bp), -5 (414 bp) and -8 (384 bp) were detected in foetal, immature and adult testes, but not in adult Leydig cells. FGF-10 (548 bp) was only detected in foetal testes. FGFs-6 (492 bp) and -9 (411 bp) were detected in skeletal muscle and kidney, but were not expressed in testes at any age examined. No RT-PCR products were detected in non-RT or H 2 O controls of any sample. elongating spermatids. Furthermore, the absence of expression of FGFs-1 and -2 in these cells implies an autocrine action of FGF-3 through FGFR-1 IIIb, which cannot be confirmed in the post-natal lethal FGF-3 null-mutant mice (Mansour et al. 1993) .
FGF-4 is also a major ligand acting through all but the FGFR IIIb variants. In elongating spermatids, FGF-4 could have autocrine interactions with FGFRs-1 and -2, and paracrine interactions with the FGFR-4 of Sertoli cells (Cancilla & Risbridger 1998) . FGF-4 immunostaining was particularly evident in immature adult-like Leydig cells, where all four FGFRs have been localised, and in foetal Leydig cells, where FGFR-1 was localised, suggesting a role in steroidogenesis. No expression of FGF-4 mRNA or protein was detected in adult Leydig cells. In the epithelium, previous studies have localised FGF-2 to pachytene spermatocytes (Mayerhofer et al. 1991 , Han et al. 1993 , Koike & Noumura 1994 ; our studies localised FGF-4 to pachytene spermatocytes and suggest autocrine actions on these cells through the FGFRs (Cancilla & Risbridger 1998 ).
Studies of FGF-8 in testes are equivocal. RT-PCR and in situ hybridisation showed expression in foetal mouse gonocytes at E17 but not E19 and not in adult testis (Valve Figure 4 Three-dimensional graph of testis-expressed FGF-FGFR interactions in BaF3 FGFR variant cell lines, adapted from data described by Ornitz et al. (1996) , with permission. The relative mitogenicity of each FGF is shown for each FGFR variant expressed in the testis. FGFs-1, -2 and -4 can interact with all the receptor variants shown to differing degrees, whereas FGFs-3, -5 and -8 have more restricted interactions with FGFR variants. et al. 1997) , whereas it has been found by RT-PCR in adult rat (Schmitt et al. 1996) and mouse testes (Wu et al. 1997) . We have now shown FGF-8 mRNA expression in testes at all ages examined, but we could not immunolocalise FGF-8 protein in testes from E19·5 onwards, suggesting that, if present, it has a low abundance.
The graph of FGF-FGFR interactions (Fig. 4) shows that FGF-1 acts through all receptor variants expressed in the testis. In the adult testis, FGF-1 immunostaining overlaps with that of FGFRs-1, -2 and -4 previously reported (Cancilla & Risbridger 1998) (Laslett et al. 1997) .
Detection of FGF-5 mRNA is not evidence that this ligand is essential for testicular development or function. Targeted disruption of the FGF-5 gene results in normal, healthy and fertile mice that have long hair (Hebert et al. 1994) . Similarly, FGFs-7 and -10 mRNAs were detected, yet these ligands signal through FGFR-2 IIIb , which was not detected by RT-PCR in whole testes or adult Leydig cells. This suggests that, if FGFs-7 and -10 proteins are made from these mRNAs, they are unlikely to be functional. These observations are consistent with the fertility and lack of testicular defects in FGF-7 knockout mice (Guo et al. 1996) .
With the use of a probe spanning the third coding exon and Northern blot analysis, FGF-6 mRNA in mouse skeletal muscle and heart, and a truncated mRNA transcript in adult testis were detected (de Lapeyriere et al. 1990 ). In our study, the RT-PCR primers spanned all three coding exons, yet we found no testicular FGF-6 mRNA at any age. The truncated mRNA detected in adult mouse testes (de Lapeyriere et al. 1990 ) may be a splice variant, or might not contain the full coding sequence of FGF-6. Again, FGF-6 is not essential for testicular function as FGF-6 knockout mice are fertile (Floss et al. 1997) . A previous study demonstrated specific expression of FGF-9 in brain and kidney, but not adult rat testes, using Northern blot analysis (Miyamoto et al. 1993) , and our study confirmed this finding in rats at all ages examined.
The notion that specific FGFRs and FGF ligands are functionally significant in the testis is supported by the generation of null mutant or transgenic mice for testisexpressed FGFs and FGFRs. Although targeted mutations of FGFR-1 are early embryonic lethal (Yamaguchi et al. 1994 , Deng et al. 1994 , testes of chimaeric mice with varying contributions of FGFR-1 null-mutant cells (Deng et al. 1997) display no testicular defects, suggesting compensation by other FGFRs in the testis. FGFR-2 knockout mice are early embryonic lethal (Arman et al. 1998 , inhibiting further studies. FGFR-3 knockout mice have bone and inner ear defects, but are fertile , Deng et al. 1996 , as are FGFR-4 knockout mice, which develop normally . However, mice that are mutant for both FGFR-3 and FGFR-4 display abnormalities, and are also infertile , suggesting that ligand signalling through FGFRs-3 and -4 is essential for normal testis development and function. Although the receptor variants of FGFRs-1 and -2 are present, the action of ligands through these receptors cannot compensate for the loss of signalling through FGFRs-3 and -4. Which ligands are required for this signalling? We have suggested that FGFs-1, -2, -4 and -8 should be considered. Studies are limited because, although FGF-2 knockout mice are fertile (Dono et al. 1998 , Ortega et al. 1998 , FGFs-4 and -8 knockout mice are embryonic lethal before testis development (Feldman et al. 1995 , Meyers et al. 1998 ; also, there are no FGF-1 knockout mice.
The focus of this discussion has been the potential interaction of FGF ligands and receptors, yet FGFs act through a tripartite interaction between a receptor and HSPG. Several mechanisms have been proposed that involve a co-operation between heparan sulphate-bound FGF and FGFR-bound heparan sulphate to create an Immunolocalisation of FGF-1 in (A) adult, (B) immature and (C) foetal rat testes. In the adult rat testis, Sertoli cells (S) and round (RS) spermatids were immunoreactive for FGF-1, as were the adult Leydig cells (L). In the immature testis, immunostaining for FGF-1 was observed in the immature adult-like Leydig cells (L) and peritubular cells (arrows) of the interstitium. In the foetal testis, immunoreactivity for FGF-1 was observed in gonocytes (G) and in foetal Leydig cells (L). Immunolocalisation of FGF-3 in (D) adult, (E) immature and (F) foetal rat testes. FGF-3 was specifically localised to elongating spermatids (ES) in stage I-VI tubules in adult testes; no FGF-3 immunoreactivity was observed in the interstitium. No specific staining was observed for FGF-3 in the immature rat testis, or in the foetal rat testis. Immunolocalisation of FGF-4 in (G) adult, (H) immature and (I) foetal rat testes. In the adult testis, FGF-4 was localised to step 7-12 elongating (ES) spermatids and pachytene spermatocytes from stage V-XI tubules; no immunostaining was observed in the interstitium. In the immature testis, FGF-4 immunoreactivity was observed in pachytene spermatocytes (P) and immature adult-like Leydig cells (L). In the foetal rat testis, foetal Leydig cells (L) and gonocytes (G) were immunostained for FGF-4. Tubule stages of adult testes are labelled in Roman numerals. Inset photomicrographs are serial sections with the preabsorption controls for each antibody at each age. Bars represent 50 µm. Non-specific staining of acrosomes was observed in (A) and (G).
active signalling complex (Guimond et al. 1993 , Kan et al. 1993 , Pantoliano et al. 1994 , McKeehan et al. 1998 , Pye & Gallagher 1999 . It is increasingly evident that the nature and specificity of the endogenous heparan sulphate have key roles in the specific regulation of FGF activity (Nurcombe et al. 1993 , Brickman et al. 1998 . A recent study using liver cells and liver-derived HSPGs has shown that endogenous heparan sulphate actively discriminates between different FGFs for activation of specific FGFRs (Kan et al. 1999) .
In the testis, HSPGs are present in the extracellular matrix and basement membranes of the seminiferous tubules, peritubular cells and Leydig cells (Dym 1994) . HSPGs are also integral cell-membrane-associated molecules, but their localisation to testicular cell membranes could enable them to act as a further point of regulation in growth factor-receptor interactions. This study has identified the expression of specific FGFR functional variants and FGF ligands, and indicated that future studies should be conducted on the role of other FGF ligands, in particular FGFs-1, -3 and -4.
